Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cetuximab in Advanced Sarcoma
NCT00148109Phase 2Completed
- Sponsor
- University of Michigan Rogel Cancer Center
- Start
- Jun 2005
- Primary completion
- Jul 2008
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of KL-140 in soft tissue sarcoma (STS), bone sarcoma, sponsored by University of Michigan Rogel Cancer Center. Started Jun 2005; status: completed.
02
Drugs
KL-140
03
Conditions
soft tissue sarcoma (STS)bone sarcoma
Beyond the preview
Go deeper on NCT00148109.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00148109.